FdaApplication

ANDA 212827

Back to search

Identifiers

Properties

PropertyValue
applicant_nameNATCO PHARMA LTD
application_typeANDA
approval_date2023-05-31

Products (1)

ProductActive ingredientStrengthDosage form
GEFITINIBGEFITINIB250MGTABLET;ORAL

1 product